Jay Backstrom - Jul 8, 2025 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role
Director
Signature
/s/ William Cook, as attorney-in-fact for Jay Backstrom
Stock symbol
AGIO
Transactions as of
Jul 8, 2025
Transactions value $
$0
Form type
4
Date filed
7/10/2025, 04:14 PM
Previous filing
Mar 12, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Backstrom Jay T. Director C/O AGIOS PHARMACEUTICALS, INC., 88 SIDNEY STREET, CAMBRIDGE /s/ William Cook, as attorney-in-fact for Jay Backstrom 2025-07-10 0001796398

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGIO Stock options (right to buy) Award $0 +23.4K $0.00 23.4K Jul 8, 2025 Common stock 23.4K $36.28 Direct F1
transaction AGIO Restricted stock units Award $0 +4.34K $0.00 4.34K Jul 8, 2025 Common stock 4.34K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on July 8, 2025. The shares underlying this option vest as to 25% of the underlying shares on July 8, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F2 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F3 The restricted stock units were granted on July 8, 2025. Beginning on July 8, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.